Healthtech funding in Q2 2014

European Healthtech startup funding raised during Q2 2014.

In Q2 2014, 39 European Healthtech companies closed 40 funding rounds and raised €229M in equity funding (excluding debt and grants), down 6.0% versus Q2 2013. Sweden led by capital raised, and Capricorn Partners was the most active investor. Data as of 6 Nov 2026.

Equity funding

€229M

-6.0% vs Q2 2013 · excl. debt & grants

Funding rounds

+25.0% vs Q2 2013

Companies

Top country

Sweden

Rank among sectors

7.2% of sector funding

Top-10 round share

78.8%

of disclosed capital

Funding by month

€ raised vs rounds, by month

Data table

	Funding	Rounds
Apr	€151M	17
May	€66M	11
Jun	€14M	12

Top countries

by € raised

Data table

	Healthtech — top countries by capital, Q2 2014
Sweden	€66M
Switzerland	€52M
UK	€42M
France	€33M
Finland	€15M
Belgium	€12M
Spain	€5.6M
Germany	€2.0M

Stage mix

by € raised

Data table

	Healthtech — stage mix, Q2 2014
Other	€81M
Series B	€53M
Series A	€42M
Series D+	€21M
Series C	€17M
Seed	€7.6M
Early VC	€4.0M
Growth/Late	€3.6M
Grant	€1.7M

Exits & M&A

1 Acquisition

1 exit.

Top deals

largest disclosed rounds in Q2 2014

Company	Stage	Date	Amount
Wilson Therapeutics	Other	Apr 2014	€36M
Kymab	Series B	May 2014	€29M
CRISPR Therapeutics	Series A	Apr 2014	€23M
Voluntis	Series D+	Apr 2014	€21M
Sequana Medical	Series C	Apr 2014	€17M
Bima	Series B	Apr 2014	€16M
Lifeline Ventures Oy	Other	Apr 2014	€15M
Enterome	Other	May 2014	€10M
Nyxoah	Series A	May 2014	€8.0M
OxThera	Other	Apr 2014	€7.7M
Aleva Neurotherapeutics	Series B	May 2014	€5.8M
Lifesum	Series A	Apr 2014	€4.9M
Cartagenia	Other	May 2014	€4.3M
Autifony Therapeutics	Other	Jun 2014	€3.1M
Nuubo	Other	May 2014	€3.0M

View all 40 Healthtech deals in Q2 2014 →

Top investors

most active in Q2 2014, by deal count

← All 2014 Healthtech funding